This content is from: Regulation

OTC regulation in Asia: where are we now?

Regulators across the Asia-Pacific are preparing to implement rules for clearing OTC derivatives transactions. But many jurisdictions are stumbling on legal issues

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial